Prognostic Impact and Utility of Immunoprofiling in the Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC)
- 2 December 2020
- journal article
- research article
- Published by Elsevier BV in Journal of Gastrointestinal Surgery
- Vol. 25 (1), 233-240
- https://doi.org/10.1007/s11605-020-04886-y
Abstract
No abstract availableKeywords
Funding Information
- Smith Family Fund
- NCI CCSG (P30CA012197)
- California Oncology Research Institute
This publication has 26 references indexed in Scilit:
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyThe Lancet, 2018
- Prognostic Utility of Immunoprofiling in Colon Cancer: Results from a Prospective, Multicenter Nodal Ultrastaging TrialJournal of the American College of Surgeons, 2016
- The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasisScience Translational Medicine, 2016
- Prognostic Molecular Subtypes of Low-Grade Cancer of the AppendixJournal of the American College of Surgeons, 2015
- Immunoprofiling for Prognostic Assessment of Colon Cancer: a Novel Complement to UltrastagingJournal of Gastrointestinal Surgery, 2015
- Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasisJournal of Surgical Oncology, 2014
- Surgical Outcomes of Hyperthermic Intraperitoneal ChemotherapyJAMA Surgery, 2014
- The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic SignaturesImmunity, 2013
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical OutcomeScience, 2006
- Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal CancerJournal of Clinical Oncology, 2003